Development of a Predictive Model for the Risk of Myelosuppression in Patients With Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy.
Background: Myelosuppression is a frequent complication in patients with nasopharyngeal carcinoma (NPC) undergoing chemoradiotherapy. Current clinical practice relies predominantly on treatment-phase monitoring for myelosuppression risk assessment, while effective pretreatment prediction tools are l...
| Publicado en: | Clinical Medicine Insights: Oncology Vol. 19; pp. 1 - 16 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Sage Publications Inc.
9/30/2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |